Of note, although a higher incidence of cancer has not been reported in ARPC1B patients so far, probably due to the early age of patients, our results encourage the need to monitor the disease evolution in these patients as in other defective HDR proteins that, albeit mildly affected, can lead to an increased risk of developing cancers (28–31). This evidence concerns the gene GATA3 and cancer.